Please login to the form below
Positive disruption: getting to the bottom of big data
BLH speaks to Nicole Huyghe, founder and Managing Director of data science consultancy Boobook, about the growing need from businesses for data-driven decision making.
BLH speaks to Nicole Huyghe, founder and Managing Director of data science consultancy Boobook, about the growing need from businesses for data-driven decision making.
What is Boobook?
NH: With the customer analytics side of the business, our clients ask us to analyse data provided by their customers to make an informed decision. We analyse the data and translate it into strategic insights.
The second part is personalisation and that has different components. The analysis gives us lots of interesting numbers and we have to make sure we translate it into a story, which is relevant for the business.
How we do this is equally important as the numbers are often difficult to interpret. We produce very powerful visuals – charts, PowerPoint presentations and dashboards – so that clients can look at the data from different perspectives, in a way that is easy to understand and act upon.
What type of challenges do you solve for businesses?
Most challenges are related to what we call customer segmentation. Companies want to know how they best approach the different types of customer they have. We ask the question: “How do we approach different types of customers in the best way?” This is done by identifying customer needs and underlying motivations so that people are targeted with the right messages and products. We then identify the needs and target people so that they’re more susceptible to our messages.
We also work on product development. This involves supporting companies by advising them on what their new or optimised product or service should look like. We look at the kind of features that benefit consumers and trigger their interest.
Download the full article here
Company Details
Blue Latitude Health
Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom
Latest content on this profile
- Three strategies for managing loss of exclusivity successfully
- Consultant, Claire Taylor explains why you should be strategically planning your LOE strategy years in advance.
Blue Latitude Health
- What does the future hold for Medical Affairs?
- Lori Lush, Head of Fishawack Medical, reveals why she’s driven to tell impactful scientific stories, the benefits of cross-functional collaboration, and the trends she predicts for the next five years.
Blue Latitude Health
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the life sciences industry can do to rebuild trust.
Blue Latitude Health
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and Senior Consultant Craig Moore explore the benefits of using real-world evidence and the common pitfalls life science companies should avoid.
Blue Latitude Health
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of this lost time for patients?
Blue Latitude Health
- Unpacking rare diseases in the first edition of Delta magazine
- Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization
Blue Latitude Health
